Related Experiment Video
Updated: Jul 18, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Regulation and induction of CYP3A11, CYP3A13 and CYP3A25 in C57BL/6J mouse liver
1Department of Pharmacology, School of Pharmacy and Biomedical Sciences, St Michaels Building, University of Portsmouth, White Swan Road, Portsmouth, UK.
Abstract:
This study reports that dexamethasone (DEX) significantly induces CYP3A11, CYP3A13 and CYP3A25 mRNA expression in male and female 4 days, 3 weeks and 18 weeks old C57BL/6J mice. Furthermore, CYP3A activity, as measured by erythromycin-N-demethylation, is also significantly increased. PXR, RXRalpha and CAR are known to be involved in the induction of CYP3As. Here we report nuclear receptors PXR and RXRalpha but not CAR demonstrate gender- and age-dependent expression. Also, treatment of C57BL/6J mice with DEX induces PXR but not RXRalpha or CAR. In summary, we demonstrate DEX is not only able to up-regulate CYP3A expression and activity, but also the nuclear receptor PXR through which it may exert this effect. Furthermore, the gender- and age-dependent pattern of basal PXR and RXRalpha expression is similar to the 3 CYP3As analysed.
Insights
Dexamethasone (DEX) boosts CYP3A gene expression and activity in mice. This effect is linked to the induction of the pregnane X receptor (PXR), a key nuclear receptor involved in regulating these genes.
Area of Science:
- Pharmacology
- Molecular Biology
- Toxicology
Background:
- Cytochrome P450 (CYP) enzymes, particularly CYP3A family members, play crucial roles in drug metabolism and detoxification.
- Nuclear receptors like the pregnane X receptor (PXR), retinoid X receptor alpha (RXRalpha), and constitutive androstane receptor (CAR) are known regulators of CYP expression.
- Understanding the regulation of CYP enzymes is vital for predicting drug efficacy and toxicity.
Purpose of the Study:
- To investigate the effect of dexamethasone (DEX) on CYP3A mRNA expression and activity in mice.
- To examine the expression patterns of nuclear receptors PXR, RXRalpha, and CAR in response to DEX treatment.
- To elucidate the role of nuclear receptors in mediating DEX-induced CYP3A regulation.
Main Methods:
- Quantitative real-time PCR (qPCR) was used to measure mRNA expression levels of CYP3A11, CYP3A13, CYP3A25, PXR, RXRalpha, and CAR.
- CYP3A activity was assessed by measuring erythromycin-N-demethylation.
- Experiments were conducted on male and female C57BL/6J mice of various ages (4 days, 3 weeks, 18 weeks).
- Mice were treated with DEX to evaluate its inductive effects.
Main Results:
- Dexamethasone (DEX) significantly upregulated CYP3A11, CYP3A13, and CYP3A25 mRNA expression across different ages and genders.
- DEX treatment also significantly increased CYP3A activity, as indicated by enhanced erythromycin-N-demethylation.
- Nuclear receptor expression showed gender- and age-dependent patterns; DEX specifically induced PXR expression, but not RXRalpha or CAR.
- The basal expression patterns of PXR and RXRalpha mirrored those of the studied CYP3A enzymes.
Conclusions:
- Dexamethasone effectively induces CYP3A expression and activity in mice.
- The induction of CYP3A by DEX is likely mediated through the upregulation of the pregnane X receptor (PXR).
- The observed gender- and age-dependent expression of PXR and RXRalpha suggests their involvement in the differential regulation of CYP3A enzymes.

